Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,264.00
Bid: 12,280.00
Ask: 12,282.00
Change: 146.00 (1.20%)
Spread: 2.00 (0.016%)
Open: 12,244.00
High: 12,384.00
Low: 12,228.00
Prev. Close: 12,118.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-European stocks flat despite rise in cyclicals

Tue, 12th Jan 2021 10:06

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)

* Cyclical stocks lead gains again

* London's FTSE hit by stronger pound

* Maersk gains after Berenberg upgrade
(Updates to market close)

By Sruthi Shankar

Jan 12 (Reuters) - European stocks closed flat on Tuesday,
with economically sensitive sectors including banks, automakers
and oil supporting markets across the continent.

The regional STOXX 600 index closed up 0.05% after
a mixed session, while Germany's DAX rose 0.1%,
France's CAC inched 0.2% lower and Britain's FTSE 100
fell 0.7%.

Investors are awaiting the start of the U.S. earnings season
this week as well as clarity on fiscal spending plans under
incoming U.S. President Joe Biden, who takes office on Jan. 20.

In Europe, automakers jumped 1.7% to lead gains
after Renault, BMW and VW
reported 2020 sales.

Their U.S. carmaking rivals also got a boost after General
Motors announced its entry into the growing electric
delivery vehicle business.

Other cyclicals such as banks, travel and leisure
and oil and gas extended last week's rally on
hopes that a larger U.S. stimulus under the incoming Biden
administration will spur faster economic recovery.

Oil majors BP and Royal Dutch Shell gained
close to 2% as crude prices hit an 11-month high on tighter
supply and expectations for a drop in U.S. inventories.

Still, losses in defensive sectors such as healthcare,
utilities and consumer staples checked gains in most markets.

"Investors are still wondering where the next big catalyst
for further upside will come from, and are painfully aware that
the COVID-19 crisis remains untamed despite the introduction of
vaccination programmes," Chris Beauchamp, chief market analyst
at IG wrote in a client note.

Britain's exporter-heavy FTSE 100 underperformed
other European markets, hit by a stronger pound and a surge in
new COVID-19 cases.

Companies listed on Europe's STOXX 600 are expected to
report a 26.3% drop in fourth-quarter earnings, data from
Refinitiv I/B/E/S shows, as restrictions to control soaring
coronavirus cases slowed an economic recovery.

That comes ahead of a clear improvement predicted for the
first two quarters of 2021, when earnings are set to rise 40.4%
and 75.1% respectively.

Maersk rose 3.4% after brokerage Berenberg
upgraded the Danish shipping company's shares to "buy", saying
earnings momentum driven by freight prices could see it run
higher.

Swiss online pharmacy chain Zur Rose hit a record
high, surging almost 15% to the top of STOXX 600, after BofA
Global Research started coverage with "buy" rating.
(Reporting by Amal S and Sruthi Shankar in Bengaluru; Editing
by Subhranshu Sahu, Arun Koyyur and Alexander Smith)

More News
Today 19:10

Sector movers: Aerospace and Defence, Pharma pace gains

(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of England's policy announcement on the following day.

Read more
Today 17:46

FTSE 100 hits record high, pound slips ahead of BoE verdict

FTSE 100 up 0.5%, FTSE 250 adds 0.4%

*

Read more
Today 16:36

London close: Stocks rise further ahead of BoE decision

(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the euro.

Read more
Today 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemic, citing "commercial reasons" and a surplus of updated jabs.

Read more
Today 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.